title: Mastitis in post-partum dairy cows.
abstract: Transition from the dry period to lactation is a high risk period for the modern dairy cow. The biggest challenge at that time is mastitis. Environmental bacteria are the most problematic pathogens around parturition. Coliforms are able to cause severe infections in multiparous cows, and heifers are likely to be infected with coagulase-negative staphylococci. During the periparturient period, hormonal and other factors make the dairy cows more or less immunocompromised. A successful mastitis control programme is focused on the management of dry and calving cows and heifers. Clean and comfortable environment, proper feeding and adequate supplementation of the diet with vitamins and trace elements are essential for maintaining good udder health. Strategies which would enhance closure of the teat canal in the beginning of the dry period and would protect teat end from bacteria until the keratin plug has formed decrease the risk for mastitis after calving. Dry cow therapy has been used with considerable success. Yet, a selective approach could be recommended rather than blanket therapy. Non-antibiotic approaches can be useful tools to prevent new infections during the dry period, in herds where the risk for environmental mastitis is high. Vaccination has been suggested as a means to support the immune defence of the dairy cow around parturition. In some countries, implementation of Escherichia coli core antigen vaccine has reduced the incidence of severe coliform mastitis after calving.
authors.affiliation: Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Saarentaus, Finland. satu.pyorala@helsinki.fi
authors.forename: S
authors.initials: S
authors.lastname: Pyörälä
mesh_terms: D000822:Animal Husbandry / Q000379:methods; D000824:Animal Nutritional Physiological Phenomena / Q000502:physiology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002417:Cattle; D003612:Dairying / Q000379:methods; D024881:Drug Resistance, Bacterial; D005260:Female; D006920:Hygiene; D007774:Lactation / Q000502:physiology; D008321:Mammary Glands, Animal / Q000187:drug effects* / Q000382:microbiology*; D008414:Mastitis, Bovine / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents